Alexander Chern, Alexandria L Irace1, Justin S Golub1. 1. Department of Otolaryngology-Head and Neck Surgery, newYork-Presbyterian/Columbia University Irving Medical Center and Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Abstract
OBJECTIVE: There is a known association between hearing loss (HL) and depressive symptoms. The objective was to establish if there is a stronger association with the left or right ear. STUDY DESIGN: Cross-sectional analysis of an ongoing prospective epidemiologic cohort study. SETTING: Hispanic Community Health Study (US, multicentered). PATIENTS: Five thousand three hundred and twenty-eight adults 2:50 years old. INTERVENTIONS: None. MAIN OUTCOME MEASURES: The main outcome was depressive symptoms, measured by the 10-Item Center for Epidemiologic Studies Depression Scale-10 (CESD-10) and defined continuously and binarily. Subjects with CESD-10 2: 10 were categorized as having clinically significant depressive symptoms (CSDS). Linear and logistic regressions were performed to assess the association between depressive symptoms and hearing in each ear, controlling for hearing aid use, age, sex, educational level, study site, geographic background, cardiovascular disease, and antidepressant use. RESULTS: Mean age was 58.5 ± 6.3 years. Mean pure-tone average (PTA) was 20.3 ± 11.7 dB (range = 0 - 125) in the right ear and 20.3 ± 12.4 dB (range = -2.5 to 120) in the left. Multivariable regression adjusting for covariates demonstrated significant associations between depressive symptoms and HL in both the left and right ear. For every 20-dB worsening in right ear PTA, there was 0.89-point increase in CESD-10 (95% confidence interval = 0.59 - 1.2), and odds of CSDS increased 1.31 times (1.17 - 1.46). For every 20-dB worsening in left ear PTA, there was a 0.85-point increase in CESD-10 (0.55 - 1.14), and odds of CSDS increased 1.34 times (1.20 - 1.49). CONCLUSIONS: Worsening hearing in the right and left ears individually was associated with increased depressive symptoms and odds of CSDS. No ear laterality was demonstrated.
OBJECTIVE: There is a known association between hearing loss (HL) and depressive symptoms. The objective was to establish if there is a stronger association with the left or right ear. STUDY DESIGN: Cross-sectional analysis of an ongoing prospective epidemiologic cohort study. SETTING: Hispanic Community Health Study (US, multicentered). PATIENTS: Five thousand three hundred and twenty-eight adults 2:50 years old. INTERVENTIONS: None. MAIN OUTCOME MEASURES: The main outcome was depressive symptoms, measured by the 10-Item Center for Epidemiologic Studies Depression Scale-10 (CESD-10) and defined continuously and binarily. Subjects with CESD-10 2: 10 were categorized as having clinically significant depressive symptoms (CSDS). Linear and logistic regressions were performed to assess the association between depressive symptoms and hearing in each ear, controlling for hearing aid use, age, sex, educational level, study site, geographic background, cardiovascular disease, and antidepressant use. RESULTS: Mean age was 58.5 ± 6.3 years. Mean pure-tone average (PTA) was 20.3 ± 11.7 dB (range = 0 - 125) in the right ear and 20.3 ± 12.4 dB (range = -2.5 to 120) in the left. Multivariable regression adjusting for covariates demonstrated significant associations between depressive symptoms and HL in both the left and right ear. For every 20-dB worsening in right ear PTA, there was 0.89-point increase in CESD-10 (95% confidence interval = 0.59 - 1.2), and odds of CSDS increased 1.31 times (1.17 - 1.46). For every 20-dB worsening in left ear PTA, there was a 0.85-point increase in CESD-10 (0.55 - 1.14), and odds of CSDS increased 1.34 times (1.20 - 1.49). CONCLUSIONS: Worsening hearing in the right and left ears individually was associated with increased depressive symptoms and odds of CSDS. No ear laterality was demonstrated.
Authors: Sidney H Kennedy; Peter Giacobbe; Sakina J Rizvi; Franca M Placenza; Yasunori Nishikawa; Helen S Mayberg; Andres M Lozano Journal: Am J Psychiatry Date: 2011-02-01 Impact factor: 18.112
Authors: Wayne C Drevets; Joseph L Price; Mark E Bardgett; Theodore Reich; Richard D Todd; Marcus E Raichle Journal: Pharmacol Biochem Behav Date: 2002-03 Impact factor: 3.533
Authors: Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg Journal: Biol Psychiatry Date: 2008-10-08 Impact factor: 13.382
Authors: Matthew J Leskowitz; Francesco F Caruana; Barbara Siedlecki; Z Jason Qian; Jaclyn B Spitzer; Anil K Lalwani Journal: Laryngoscope Date: 2016-04-04 Impact factor: 3.325
Authors: Patrick J Brown; Steven P Roose; Robert Fieo; Xinhua Liu; Taina Rantanen; Joel R Sneed; Bret R Rutherford; D P Devanand; Kirsten Avlund Journal: Am J Geriatr Psychiatry Date: 2013-08-20 Impact factor: 4.105
Authors: Nicole M Armstrong; Yang An; Jimit Doshi; Guray Erus; Luigi Ferrucci; Christos Davatzikos; Jennifer A Deal; Frank R Lin; Susan M Resnick Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-09-01 Impact factor: 6.223